Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1990-7-11
|
pubmed:abstractText |
A "hybrid gene" (MTKb) comprised of the human metallothionein IIA promoter ligated to the genomic sequence of the major histocompatibility complex class I (H-2Kb) gene was subcloned into the expression vector pSV2neo and transfected into the natural killer (NK) cell-sensitive YAC-1 lymphoma. The Kb gene product was readily detectable on the cell surface of G418-resistant transfectants using both Kb-specific monoclonal antibodies and H-2b-specific cytolytic T cells. Unlike control pSV2neo transfectants, MTKb-pSV2neo transfectants were relatively resistant to lysis by NK cells from H-2a, H-2b, H-2k or H-2 (a x b)F1 haplotype mice. These data strongly suggest that the effects of MHC expression on susceptibility to NK cells can be mediated by a single and well-defined class I molecule, Kb.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0014-2980
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
20
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
841-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2347364-Animals,
pubmed-meshheading:2347364-Clone Cells,
pubmed-meshheading:2347364-Female,
pubmed-meshheading:2347364-H-2 Antigens,
pubmed-meshheading:2347364-Killer Cells, Natural,
pubmed-meshheading:2347364-Lymphoma,
pubmed-meshheading:2347364-Metallothionein,
pubmed-meshheading:2347364-Mice,
pubmed-meshheading:2347364-Mice, Inbred C57BL,
pubmed-meshheading:2347364-Mice, Inbred CBA,
pubmed-meshheading:2347364-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:2347364-Transfection,
pubmed-meshheading:2347364-Zinc
|
pubmed:year |
1990
|
pubmed:articleTitle |
Class I (H-2Kb) gene transfection reduces susceptibility of YAC-1 lymphoma targets to natural killer cells.
|
pubmed:affiliation |
Mount Sinai Hospital Research Institute, University of Toronto, Ontario, Canada.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|